Page last updated: 2024-11-08

isoflurophate and Psychotic Disorders

isoflurophate has been researched along with Psychotic Disorders in 1 studies

Isoflurophate: A di-isopropyl-fluorophosphate which is an irreversible cholinesterase inhibitor used to investigate the NERVOUS SYSTEM.

Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ROWNTREE, DW1
NEVIN, S1
WILSON, A1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomised Double-Blinded Placebo-Controlled Trial to Assess the Efficacy and Safety of Scopolamine Compared to Placebo in Individuals With Bipolar Disorder Who Are Experiencing a Depressive Episode[NCT04211961]Phase 250 participants (Anticipated)Interventional2021-03-23Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for isoflurophate and Psychotic Disorders

ArticleYear
The effects of diisopropylfluorophosphonate in schizophrenia and manic depressive psychosis.
    Journal of neurology, neurosurgery, and psychiatry, 1950, Volume: 13, Issue:1

    Topics: Bipolar Disorder; Fluorides; Humans; Isoflurophate; Phosphates; Psychotic Disorders; Schizophrenia

1950